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guy.lloyd@nhs.netAbstractResting echocardiography measurements are poor predictors of exercise capacity and
symptoms in patients with heart failure (HF). Stress echocardiography may provide
additional information and can be expressed using left ventricular ejection fraction (LVEF),
or diastolic parameters (E/E 0), but LVEF has some major limitations. Systolic annular velocity
(S 0) provides a measure of longitudinal systolic function, which is relatively easy to obtain
and shows a good relationship with exercise capacity. The objective of this study was to
investigate the relationship among S 0, E/E 0 and LVEF obtained during stress echocardio-
graphy and both mortality and hospitalisation. A secondary objective was to compare S 0
measured using a simplified two-wall model. A total of 80 patients with stable HF underwent
exercise stress echocardiography and simultaneous cardiopulmonary exercise testing.
Volumetric and tissue velocity imaging (TVI) measurements were obtained, as was peak
oxygen uptake (VO2 peak). Of the total number of patients, 11 died and 22 required cardiac
hospitalisation. S 0 at peak exertion was a powerful predictor for death and hospitalisation.
Cut-off points of 5.3 cm/s for death and 5.7 cm/s for hospitalisation provided optimum
sensitivity and specificity. This study suggests that, in patients with systolic HF, S 0 at peak
exertion calculated from the averaged spectral TVI systolic velocity of six myocardial
segments, or using a simplified measure of twomyocardial segments, is a powerful predictor
of future events and stronger than LVEF, diastolic velocities at rest or exercise and VO2 peak.
Results indicate thatmeasuring S 0 during exercise echocardiographymight play an important
role in understanding the likelihood of adverse clinical outcomes in patients with HF.Key Words
" stress echocardiography
" tissue Doppler imaging
" left ventricular ejection
fractionIntroductionSystolic heart failure (HF) is a major cause of mortality
and morbidity, and its prevalence is increasing due to
the ageing population (1). It is conventionally defined
by demonstrating typical clinical symptoms and
signs associated with compatible findings on a restingechocardiogram (2). Patients with systolic dysfunction
respond to a range of physical and medical therapies, but
nonetheless have a poor prognosis (3). Resting echo-
cardiography and particularly left ventricular ejection
fraction (LVEF) has been shown to be a poor predictor ofwww.echorespract.com
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additional value that stress echocardiography has on
exercise capacity and symptoms (5, 6, 7) and prognosis
(8, 9, 10, 11).
Stress echocardiography adds prognostic value in
patients with myocardial ischaemia secondary to coro-
nary artery disease (12, 13). Furthermore, echocardio-
graphic data during exercise provide additional
information regarding patients’ overall exercise ability
(14). Patients with HF demonstrating an increase in LVEF
of 5% (in absolute terms) or more during stress
echocardiography have a better prognosis (15, 16, 17).
However, LVEF can be challenging to obtain reliably
and has some major limitations including a lack of
reproducibility, dependence on loading conditions and
it only describes maximum displacement at the end of
systole meaning the longitudinal component of systolic
function is not completely described. Systolic annular
velocities obtained during stress echocardiography show
a strong relationship with exercise tolerance (6, 18) and
the change in early diastolic velocity has also proven
predictive (19). The relationship between both systolic
and diastolic velocities and prognosis, however, remains
undetermined. Therefore, the objective of this study was
to investigate whether systolic velocity (S 0), diastolic
reserve (E/E 0) and LVEF, all of which describe different
aspects of cardiac function, would relate to mortality
and cardiac hospitalisation in an established cohort of
patients with systolic HF who had undergone stress
echocardiography and cardiopulmonary exercise testing
as part of a research study.Methods
This was a retrospective longitudinal study of 80 patients
with systolic HF participating in cohort studies under-
taken at our institution using the same echocardiography
and cardiopulmonary exercise test (CPET) protocols (20)
(explained in more detail below). All patients were
medically treated for systolic HF and had been stable
on medical therapy for at least 1 month before study
inclusion. The definition of systolic HF was made by the
combination of appropriate symptoms and a depressed
LV on echocardiography. Exclusion criteria included
unstable angina, symptomatic angina, evidence of revers-
ible ischaemia, PCI (percutaneous coronary intervention)
or coronary artery bypass graft (CABG) within the last
6 months, severe lung disease or poor echocardiographic
windows. Informed written consent was obtained and all
studies were approved by the local ethical committee.www.echorespract.comEchocardiography
Echocardiography was performed using a GE Vivid 7
platform (Vingmed-General Electric, Horten, Norway)
equipped with a phased-array 3.5 MHz transducer. Two-
dimensional, spectral Doppler and tissue velocity imaging
(TVI) were obtained at rest and during exercise. LV
volumes and LVEF were calculated using Simpson’s
biplane method in the apical four-chamber and two-
chamber views. Transmitral Doppler was obtained by
placing a pulsed wave Doppler sample volume at the tips
of the mitral leaflets. Pulsed wave Doppler for cardiac
output assessment was taken in the five-chamber view
1 cm below the aortic valve. TVI was performed with the
sample volume placed at mitral annulus in the three-
apical views. Exercise S 0 (defined as the highest velocity
during systole after the end of isovolumetric contraction)
was obtained from six peri-annular sites of the mitral
annulus (septal, lateral, inferior, anterior, posterior and
anteroseptal). At least three cardiac cycles were obtained
and S 0 was averaged for each segment and all available
S 0 were averaged. At instances where a reproducible TVI
recording was not achieved, all available recordings
were used to calculate the average. Myocardial velocity
during early diastole (E 0) was measured on the lateral wall
because this was laid down in one of the study protocols
(because of the inclusion of a proportion of patients who
had undergone previous cardiac surgery, in whom septal
diastolic velocity might not have been representative).
Images were obtained in real time and analysed after each
study. Images were stored offline.Cardiopulmonary exercise test
A recumbent cycle ergometer (ERG 911 S/L, Schiller, Baar,
Switzerland) was used. Peak oxygen uptake (VO2 peak) was
used as the main outcome variable as it has been
previously shown to be a strong predictor of mortality in
patients with systolic HF (21, 22). Patients were asked to
continue to take their medication as usual. At the start of
the test a 3-min rest period was included followed by a
3 min of warm-up period. Exercise protocols were indivi-
dually determined based on functional status. Work rate
(5, 10, 15 or 20 W) increased every minute until voluntary
exhaustion aiming for 6–10 min of exercise. Heart rate,
blood pressure and oxygen saturation were monitored
throughout. Oxygen uptake, carbon dioxide production
and ventilation were continuously measured and deri-
ved using a calibrated breath-by-breath analyser (Schiller
Powercube AT-104 PC, Ganzhorn, Baar, Switzerland).20
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effort (7). Echocardiography measurements commenced
when patients were close to finishing the test when the
RER was exceeding 0.95 and if patients were not taking
b-blockers in combination with a peak predicted HR
O85%. All measurements were taken within 90 s of
finishing exercise. Patients were verbally encouraged to
exercise until maximal exertion. All tests were performed
according to the exercise testing guidelines (23). VO2 peak
was expressed as the highest value from an average of
30 s during the final stage of the exercise test.Follow-up
All-cause mortality and cardiac hospitalisation end points
were evaluated by cross-referencing with the hospital
information system (which is linked to the UK registry
of death), the clinical case notes, contacting the primary
care physician and, where necessary, contacting the
patient by telephone. No patient was lost to follow-up.
Where hospitalisations had occurred, all best endeavours
to evaluate the notes were made to ensure that the
hospitalisation was HF related. Data on re-admission
were based on the primary diagnosis at discharge.Statistical analyses
All data are expressed as meanGS.D. or percentage for
continuous variables and categorical data are expressed as
absolute values and percentages. Pearson’s correlation
coefficients or Spearman’s coefficients were used to
determine relationship between echocardiographic vari-
ables and exercise tolerance. Differences between groups
were investigated using the Student’s t-test for continuous
data and the c2 test for categorical data. All variables were
assessed for univariate statistical significance using Cox’s
proportional hazard regression model for mortality and
hospitalisation. All significant predictors of outcome were
entered into multivariate Cox’s proportional model
(forward selection) to identify the strongest predictors
of mortality or cardiac hospitalisation. Another Cox’s
regression analysis was performed interchanging the
average systolic velocities for the average of the septal
and lateral walls. Data from Cox’s regression analysis
are expressed as hazard ratios (HRs) with 95% CI.
Receiver operating characteristics (ROC) curves were
used to determine the optimal prognostic threshold
value (highest combination of sensitivity/specificity) for
mortality and hospitalisation. Interobserver variability
was undertaken from 12 randomly selected subjects andwww.echorespract.comintraclass correlations (ICCs) were calculated. All statisti-
cal analyses were performed using the Statistical Package
for the Social Sciences (SPSS version 20.0; SPSS, Inc.).
A P value of !0.05 was considered significant.Results
Baseline characteristics are given in Table 1. A total of 80
patients were included in the study, 11 patients died and
22 required non-elective hospital admissions during a
median follow-up of 24 months (range 3–40 months). Of
the remaining number of patients, 50 suffered from
ischaemic heart disease, and, of them, 16 had a previous
CABG and 13 a previous PCI. A proportion of patients
(nZ23) previously underwent cardiac resynchronisation
therapy (CRT) before inclusion in the research study,
30 patients had been clinically approved to receive CRT
and the remaining 27 did not qualify for CRT at the time of
the study. Although no significant differences were found
for the presence of ischaemic heart disease, there was a
trend observed for hospitalisation (PZ0.25) and survival
(PZ0.15) (Table 1).
No differences in age, sex, electrolytes, hypertension,
left bundle branch block, diabetes, non-significant valvu-
lar heart disease, presence of CRT, previous CABG or PCI
were observed between those with and without events.
A difference was observed for the use of angiotensin II
receptor blocker (ARB) and diuretics for patients who have
been hospitalised. No other difference in drug history was
observed (Table 1).
Of 480 available segments from TVI analysis, 92%
were positively identified at rest vs 81% during stress
echocardiography. All six myocardial segments were
evaluable in 58 patients at rest and 34 patients during
exercise. The septal and lateral systolic velocities were
identified in all 80 patients at rest and in 78 patients
during exercise. The apical long-axis view was most
frequently not evaluable, in particular the anteroseptal
segment. Nevertheless, in 79 patients at rest and in 72
patients during exercise, at least four segments were
accurately identified. The mean TVI value of all six
segments correlated well with the mean of the septal and
the lateral walls for rest (rZ0.93, P!0.001) and exercise
(rZ0.94, P!0.001).
Maximal exercise tolerance described using VO2 peak
was significantly higher in survivors than in non-survivors
(1.2G0.4 l/min vs 0.9G0.3 l/min, PZ0.04). However,
no difference was found between patients who were
hospitalised and those who were not (1.2G0.5 l/min vs
1.1G0.3 l/min). A regression analysis showed a weak21
Table 1 Baseline clinical characteristics. Data are expressed as meanGS.D. or as number (%) of patients.
All patients
(nZ80)
Survivors
(nZ69)
Non-survivors
(nZ11)
No hospitalisation
(nZ58)
Hospitalisation
(nZ22)
Age (years) 72G9 71G9 74G7 71G10 74G7
Male 51 (64%) 44 7 39 12
IHD 50 (63%) 41 9 34 16
Hypertension 23 (29%) 19 4 16 7
LBBB 42 (53%) 38 4 32 10
Diabetes mellitus 15 (19%) 14 1 10 5
Valvular heart disease 9 (11%) 7 2 6 3
CRT 23 (29%) 19 4 15 8
CABG 16 (20%) 15 1 11 5
PCI 13 (16%) 10 3 9 4
ACE inhibitor 50 (63) 42 8 32 18
b-blocker 57 (71%) 49 8 43 14
Digoxin 8 (10%) 7 1 6 2
Amiodarone 17 (21%) 13 4 11 6
ARB 24 (30%) 21 3 21* 3
Diuretic 59 (74%) 49 10 39* 20
Statin 54 (68%) 49 5 39 15
Serum creatinine (mmol/l) 105G35.9 103G34 121G45 101G32 118G42
Serum sodium (mmol/l) 139G3.0 139G3 140G3 140G3 139G3
Resting heart rate (beats/min) 68G15 67G15 71G16 68G16 67G11
Exercise heart rate (beats/min) 99G23 99G22 96G16 102G24 91G20
Resting cardiac output (l/min) 3.9G1.4 3.9G1.4 3.7G1.3 3.9G1.4 3.9G1.6
Exercise cardiac output (l/min) 6.7G2.2 6.9G2.3 5.4G1.6 6.9G2.3 6.3G2.0
*P!0.05; ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; CABG, coronary artery bypass graft; CRT, cardiac resynchronisation
therapy; IHD, ischaemic heart disease; LBBB, left bundle branch block; PCI, percutaneous coronary intervention.
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LVEF (rZ0.35, P!0.05; rZ0.5, P!0.05 respectively),
while a moderate correlation was found for exercise S 0
(rZ0.66, P!0.001).
Echocardiographic, exercise and functional para-
meters for survivors and non-survivors, as well as thoseTable 2 Mean echocardiographic, exercise and functional parame
Mortality Survivors Non-surv
S 0 at rest (cm/s) 5.4G1.6 3.7G1
S 0 at exercise (cm/s) 7.1G2.2 4.4G1
LVEF at rest 33G11 24G6
LVEF at exercise 40G14 28G8
E 0 at rest (cm/s) 6.4G2.6 5.4G2
E 0 at exercise (cm/s) 10.1G4.6 7.1G2
E/E 0 at rest 12.6G7.4 18.7G9
E/E 0 at exercise 12.1G7.2 18.2G7
VO2 peak (l/min) 1.2G0.4 0.94G0
EDV 158G59 180G6
ESV 108G46 139G5
EDD 5.8G0.8 6.5G0
ESD 4.8G0.9 5.6G1
LA diameter 3.9G0.8 4.4G0
NYHA 2.2G0.8 2.5G0
LVEF, left ventricular ejection fraction; S 0, systolic velocity; E 0, myocardial veloci
peak, peak oxygen uptake; EDV, end-diastolic volume; ESV, end-systolic volume;
NYHA, New York Heart Association class.
aSurvivors vs non-survivors or hospitalisation vs no hospitalisation P!0.01.
bSurvivors vs non-survivors or hospitalisation vs no hospitalisation P!0.05.
www.echorespract.comwho were and were not hospitalised, are presented in
Table 2. There was a significant difference in systolic
velocities at rest and exercise, LVEF at rest and exercise,
E/E 0 at rest and exercise, VO2 peak, and end diastolic
dimensions between survivors and non-survivors. Fewer
differences were observed between those who were andters (meanGS.D.).
ivors No hospitalisation Hospitalisation
.2a 5.3G1.7 4.5G1.5b
.3a 7.2G2.4 5.5G1.6b
b 33G10 27G11a
a 39G14 35G13
.1 6.4G2.6 5.9G2.3
.3 10.2G4.7 8.5G3.8
.0a 12.6G7.9 15.0G7.2
.1a 12.2G7.7 14.8G6.8
.3a 1.2G0.5 1.1G0.3
3 161G61 162G54
6 109G48 121G49
.9b 5.8G0.8 6.3G0.9b
.4 4.7G1.0 5.6G0.9a
.6 3.9G0.8 4.2G0.6
.7 2.2G0.7 2.2G0.8
ty early diastole; E/E 0, transmitral-to-basal early diastolic velocity ratio; VO2
EDD, end-diastolic dimensions; ESD, end-systolic dimensions; LA, left atrium;
22
Table 3 Univariate predictors of mortality and cardiac admission.
Mortality HR (95% CI) P value Hospitalisation HR (95% CI) P value
S 0 at rest (cm/s) 0.46 (0.29–0.75) 0.002 S 0 at rest (cm/s) 0.67 (0.50–0.90) 0.008
S 0 at exercise (cm/s) 0.47 (0.31–0.71) !0.0001 S 0 at exercise (cm/s) 0.65 (0.52–0.83) !0.0001
LVEF at rest 0.91 (0.85–0.98) 0.01 LVEF at rest 0.94 (0.90–0.98) 0.008
LVEF at exercise 0.93 (0.88–0.98) 0.01 E/E 0 at exercise 1.05 (1.00–1.09) 0.04
E/E 0 at rest 1.07 (1.00–1.14) 0.03 EDD 1.82 (1.03–3.20) 0.04
E/E 0 at exercise 1.07 (1.01–1.12) 0.01 ESD 2.23 (1.31–3.77) 0.003
VO2 peak (l/min) 0.10 (0.01–0.76) 0.03 Creatinine 1.01 (1.00–1.02) 0.04
ESV 1.01 (1.00–1.02) 0.05 Diuretics 0.23 (0.05–1.00) 0.05
LVEF, left ventricular ejection fraction; S 0, systolic velocity; E 0, myocardial velocity early diastole; E/E 0, transmitral-to-basal early diastolic velocity ratio;
VO2 peak, peak oxygen uptake; ESV, end-systolic volume.
1.0
0.8
0.6
0.4
0.2
0.0
Cu
m
u
la
tiv
e
 s
u
rv
iva
l r
a
te
0 10 20 30 40
Months
1.0
0.8
0.6
0.4
0.2
0.0
Cu
m
u
la
tiv
e
 h
os
pi
ta
lis
at
io
n-
fre
e 
ra
te
0 10 20 30 40
Months
Log-rank = P<0.001
S≥5.3 cm/s
S<5.3 cm/s
Log-rank = P<0.001
≥5.7 cm/s
<5.7 cm/s
Figure 1
Kaplan–Meier curves for mortality (top) and hospitalisation (bottom).
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and end diastolic dimensions remained significant.
Significant univariate predictors are given in Table 3.
None of the clinical characteristics in Table 1 were
univariate predictors for death; for hospitalisation, only
diuretics were a univariate predictor (Table 3). Aetiology
of HF was not a univariate predictor for either mortality
or hospitalisation. After all the variables that predicted
mortality and hospitalisation (Table 3) on univariate
Cox’s regression analysis were entered into a forward
multivariate Cox’s regression model, only exercise S 0
emerged as a significant predictor of mortality (HR: 0.36;
95% CI: 0.19–0.67; PZ0.001) and hospitalisation (HR:
0.62; 95% CI: 0.45–0.85; PZ0.003). This model retained
its predictive power when exercise S 0 was substituted by
the average septum and lateral S 0 for mortality (HR: 0.42;
95% CI: 0.24–0.73; PZ0.002) and hospitalisation (HR:
0.54; 95% CI: 0.37–0.81; PZ0.003).
A ROC analysis was performed for mortality and
systolic velocity has the largest area under the curve of
0.86 (95% CI: 0.75–0.96). A cut-off of 5.3 cm/s for exercise
S 0 showed a sensitivity and specificity of 82 and 80%,
respectively, for mortality. Similarly, for hospitalisation,
a ROC analysis for exercise S 0 has an area under the
curve of 0.71 (95% CI: 0.58–0.83), which resulted in a
cut-off of 5.7 cm/s representing a sensitivity of 59% and
a specificity of 74%. Kaplan–Meier curves were generated
using these cut-offs (see Fig. 1).
Interobserver variability measured by ICC was
stronger for exercise S 0 (ICC: 0.96; 95% CI: 0.88–0.99)
compared with exercise LVEF (ICC: 0.57; 95% CI:K0.82 to
0.92), exercise E 0 (ICC: 0.83; 95% CI: 0.38–0.95) and
exercise E/E 0 (ICC: 0.84; 95% CI: 0.40–0.96). Similarly,
for the intraobserver variability, the ICC was stronger for
TVI-derived parameters, exercise S 0 (ICC: 0.97; 95% CI:
0.86–0.99) and exercise E 0 (ICC: 0.99; 95% CI: 0.94–0.99)www.echorespract.comcompared with exercise LVEF (ICC: 0.88; 95% CI: 0.50–
0.96) and exercise E/E 0 (ICC: 0.85; 95% CI:K0.24 to 0.98).Discussion
This study suggests that, in patients with systolic HF, S 0 at
peak exertion calculated from the averaged spectral TVI
systolic velocity of six myocardial segments, or using a23
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powerful predictor of future events and stronger than
LVEF, diastolic velocities at rest or exercise, and VO2 peak.
It retains its prognostic value after adjustment for clinical
data, peak exercise capacity, functional parameters and
other echocardiographic data. Cut-off points of 5.3 cm/s
for death and 5.7 cm/s for hospitalisation provided
optimum sensitivity and specificity, which were 82 and
80% for mortality and 59 and 74% for hospitalisation.
Surprisingly, exercise S 0 proved to be a stronger predictor
than VO2 peak despite being moderately co-correlated, and
VO2 peak having been highly predictive of mortality in
other studies (24, 25). This study confirms the limitation of
resting echocardiography in predicting either prognosis or
exercise capacity in patients with systolic HF (9, 10, 24,
26, 27). Inter- and intraobserver variabilities were excellent
for S0 at exercise unlike LVEF at exercise, which was less
reliable; this is in agreement with previous studies (28, 29).
The most widely used parameter to characterise HF is
resting LVEF, but this measurement can be challenging.
The reasons why LVEF relates poorly to both functional
capacity (5, 6, 7, 30) and prognosis are complex (8, 9, 10,
11, 24). The reproducibility of measurement remains
sub-optimal, due partly to image quality and anatomical
factors (31). LVEF is a reflection of whole systolic
myocardial displacement and may be more dependent
on loading conditions than on other measures such as
velocity (6, 31, 32). Furthermore, LVEF poorly describes
longitudinal myocardial function, which is often affected
early in a variety of heart diseases. Previous studies have
documented only a weak relationship between LVEF
either at rest or under stress conditions and exercise
capacity, which is in agreement with our findings (6).
LVEF during dobutamine stress, where loading conditions
can be very different, has been shown to predict adverse
outcome during echocardiography and nuclear scinti-
graphy (33, 34, 35). The inability to increase LVEF during
stress echocardiography has been shown to be a strong
predictor for mortality (15).
Both systolic and diastolic TVI measures, at rest and
during exercise, have previously been demonstrated to
predict exercise capacity (20, 36, 37). A moderate
relationship between VO2 peak and S
0 was demonstrated
and both resting and stress recorded TVIs were univariate
predictors of mortality. The concept of diastolic reserve
has gained considerable interest, particularly in patients
with HF and preserved ejection fraction, where changes in
E and E 0 velocities predict exercise performance (37, 38).
Resting tissue velocity data, particularly those describing
diastole such as E 0 and A 0, have been shown to have awww.echorespract.comprognostic value (9, 10, 27). A large study by Grewal et al.
(38) found an independent association between left
ventricular diastolic dysfunction and exercise capacity.
Systolic function was not reported as all patients had a
preserved LV. Similar incremental prognostic results have
been observed in both systolic HF (9) and HF with
preserved LVEF (38, 39) for E 0 and E/E 0. One complication
when analysing all these data is the relatively close
relationship between S 0 and E 0, making it difficult to
determine which is the dominant influence. Hence, while
the primary end point of these studies may relate to
diastolic reserve, there is also a significant positive
association with systolic function that may not be fully
appreciated. One of the main determinants of early
diastolic motion (caused by mitral annular descent) is
the release of energy stored during systole, and therefore,
S 0 and other systolic measures also inevitably describe in
part the behaviour of the myocardium during early
diastole (40, 41).
Strain imaging is an alternative for describing myo-
cardial deformation (42). An important disadvantage for
TVI-derived strain is the low spatial resolution, which
results in low reproducibly and, therefore, it is not
routinely used in clinical practice (42). Two-dimensional
strain speckle tracking has the clear advantage of being
angle independent, but requires higher frame rates that
may not be sufficient to properly track the increased heart
rates at stress. This may result in under sampling,
especially during exercise. Recent studies have suggested
a potential benefit of speckle track-derived strain and
strain rate in detected reversible ischaemia during
dobutamine stress echocardiography, but routine use
especially during exercise stress echocardiography is
limited due to the limited range of heart rates that can
be sampled (12, 43).
TVI is available on most echocardiography platforms
and peak systolic and diastolic velocities are reproducible
and easy to obtain both at rest and on exercise (44). The
ability to achieve systolic velocities with a high degree for
inter- and intra-reproducibility was confirmed in this
study, unlike LVEF. The biggest challenge in achieving
averaged TVI measurements is that all walls cannot always
be assessed in all patients due to image quality. In this
study, more than half of the echocardiographic TVI
measures were not satisfactory obtained from all six
myocardial walls, and hence the protocols simplified,
where only average reading for the septal and lateral walls
were tested. This simplified protocol gave results that were
not significantly different from the average of all six walls.
This may be because, although an underlying segment24
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an apical long-axis velocity because it is tethered to other
contracting segments. Thus, the annular velocity at any
one point is an aggregate of myocardial contractility in
that and adjacent segments.Study limitations and areas for further research
A significant weakness of this study is that E 0 was measured
only in the lateral wall and not averaged over multiple
segments and, thus, may have misrepresented patients
with regional wall motion abnormalities. Møller et al. (45)
reported that E/E 0 was a strong independent predictor of
death and readmission in a cohort of patients with
previous myocardial infarction. Strain analysis either by
TVI or by speckle tracking was not used in this study and
this might have provided further insights into global and
regional deformation. The only CPET variable analysed
was VO2 peak. Although VO2 peak correlated with exercise
S 0, it failed to reach statistical significance as a predictor of
hospitalisation. There might be a closer relationship with a
submaximal parameter such as oxygen uptake efficiency
slope or the ventilatory threshold. All patients were
considered if clinically stable from an ischaemic point of
view at enrolment, and hence formal wall motion scoring
was not undertaken, hence it is possible that this might
have produced similar results due to inducible ischaemia.
Study population was small and selective as patients
were elderly and over half of the patients suffered from
stable ischaemic heart disease. Death and hospitalisations
were analysed separately as in retrospective analysis, and
it can be more challenging to interpret hospitalisation
data with absolute certainty and hence a single combined
end point was not deemed appropriate.Conclusion
While contractile reserve is recognised as a predictor of
adverse cardiac events, this is the first study to demon-
strate that the measurement of peak systolic myocardial
velocities derived from TVI during exercise predicts death
and hospital admissions to a greater extent than either
diastolic reserve or LVEF. A simplified two-wall protocol,
which makes evaluation even more straightforward, gave
equivalent results. Resting echocardiographic and clinical
parameters were less supportive in predicting future events
in this study including VO2 peak. While prospective
studies should test the hypotheses and particularly the
cut-off points identified in this study, the results suggest
that measuring S 0 during exercise echocardiography mightwww.echorespract.comhave an important role in understanding the likelihood of
adverse clinical outcomes in patients with HF.Declaration of interest
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